Avoro Capital Advisors is a global firm focused on funding & investments in biotechnology, life sciences, and specialty therapeutics. Contact us today!
Employees: 11-50
Portfolio 57
| Date | Name | Website | Total Raised | Location |
| 23.03.2023 | DICE Thera... | dicetherap... | - | United Sta... |
| 23.03.2023 | Hemab Ther... | hemab.com | $190M | Denmark, C... |
| 23.03.2023 | Madrigal | madrigalph... | - | United Sta... |
| 23.03.2023 | Kymera The... | kymeratx.c... | $197M | United Sta... |
| 23.03.2023 | Avidity Bi... | aviditybio... | $301M | United Sta... |
| 23.03.2023 | Iveric | ivericbio.... | - | - |
| 23.03.2023 | Cymabay Th... | cymabay.co... | $100M | - |
| 23.03.2023 | Amylyx | amylyx.com | $171.9M | - |
| 23.03.2023 | Syndax | syndax.com | $152.6M | - |
| - | Assembly B... | assemblybi... | - | United Sta... |
Show more
Mentions in press and media 3
| Date | Title | Description | Source |
| 14.09.2021 | Vanqua Bio Launches with $85 Million Series B Financing and ... | – Novel drug-development approach combines advanced insights into critical neuronal cell pathways wi... | marketscre... |
| 19.03.2021 | Monte Rosa closes $95 million series C round | Monte Rosa was launched from founding investor Versant Ventures’ Ridgeline Discovery Engine based in... | startuptic... |
| 19.03.2021 | Monte Rosa closes $95 million series C round | startuptic... |